Don’t Be Unprepared for COVID Surge

What’s your Reaction?


Let’s review the therapeutics.

KoolBeens, a surge is coming. May we come out of it least damaged. Still, we need to know what are the options and the best ways to reduce our risk. Let’s review. A major set of content is collected by John Snider. Shout out to John for his miticulous work.

Here is How To Plan For Omicron

The Omicron surge in the USA is going to be scary albeit short lived. Please be ready to understand possible options for you and your loved ones. Make sure you are able to discuss these with your doctor.

URL list from Monday, Jan. 17 2022

DrBeen: Continuing Medical Education Online | USMLE Prep | CME and CE marketplace | Nurse Practitioner and Physician Assistant Training Programs | Medical Student Training



About REGEN-COV Treatment for COVID-19

Fact Sheet For Health Care Providers Emergency Use Authorization (Eua) Of Bamlanivimab

Fact Sheet For Health Care Providers Emergency Use Authorization (Eua) Of Bamlanivimab And Etesevimab 12222021

GSK Sotrovimab Fact Sheet for HCP 12222021

Casirivimab and Imdevimab

Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19: A Randomized Clinical Trial | Adolescent Medicine | JAMA Internal Medicine | JAMA Network

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial – The Lancet

Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis – PubMed

Melatonin interferes with COVID-19 at several distinct ROS-related steps – ScienceDirect

Universally available herbal teas based on sage and perilla elicit potent antiviral activity against SARS-CoV-2 in vitro | bioRxiv

Full article: Low-dose aspirin for early COVID-19: does the early bird catch the worm?

Pathogens | Free Full-Text | Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells | HTML

COVID-19 Clinical Trials | Temple Health

Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting – Full Text View –

A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness – Full Text View –

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial – The Lancet Global Health

Nation’s first ivermectin clinical trial now 50 percent enrolled | Medical School – University of Minnesota

Home | COVID-OUT: Outpatient Treatment for SARS-CoV-2 Infection, a Factorial Randomized Trial

Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19 – Full Text View –

Effect of forest bathing trips on human immune function – PMC

The effect of herbal remedies on the production of human inflammatory and anti-inflammatory cytokines – PubMed

Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B 12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19) – PubMed

Advice for patients with new-onset anosmia during COVID-19 pandemic.pdf

What’s your Reaction?


Click to comment

You must be logged in to post a comment Login

Leave a Reply

To Top